Factors influencing postoperative recurrence of early-stage non-small cell lung cancer

被引:2
|
作者
Akcam, Tevfik Ilker [1 ]
Tekneci, Ahmet Kayahan [2 ]
Ergin, Tiffany Melissa [1 ]
Memmedov, Rza [1 ]
Ergonul, Ayse Gul [1 ]
Ozdil, Ali [1 ]
Turhan, Kutsal [1 ]
Cakan, Alpaslan [1 ]
Cagirici, Ufuk [1 ]
机构
[1] Ege Univ, Dept Thorac Surg, Sch Med, Izmir, Turkiye
[2] Hlth Sci Univ Izmir, Tepecik Educ & Res Hosp, Dept Thorac Surg, Izmir, Turkiye
关键词
Non-small cell lung cancer; recurrence; survival; histopathology; STAS; surgery; PROGNOSTIC IMPACT; 2; CM; RESECTION; ADENOCARCINOMA; IA; CLASSIFICATION; LOBECTOMY; INVASION; PATTERN;
D O I
10.1080/00015458.2023.2231210
中图分类号
R61 [外科手术学];
学科分类号
摘要
PurposeThis study aims to explain the factors that may influence recurrence after surgical resection for early non-small cell lung cancer (NSCLC).MethodsA retrospective analysis was made of 302 patients who underwent lung resection for stage I-IIA NSCLC in our clinic between January 2014 and August 2021.ResultsThe recurrence rate was higher in patients with squamous cell carcinoma (SCC) than in those with adenocarcinoma (AC) (p = 0.004). Disease-free survival (DFS) was shorter in SCC (p = 0.004). According to histopathological subtypes, the presence of lymphovascular invasion (LVI), vascular invasion (VI), visceral pleural invasion (VPI) and tumor spread through air spaces (STAS) caused an increased risk of recurrence ((p = 0.004), (p = 0.001), (p = 0.047), (p = < 0.001)) and shorter DFS ((p = 0.002), (p = < 0.001), (p = 0.038), (p = < 0.001)). LVI and VI was more common in patients with distant recurrence (p = 0.020, p = 0.002), while the STAS was more common with locoregional recurrence (p = 0.003).ConclusionThe presence of LVI, VI, VPI, and STAS are negative risk factors for recurrence and DFS in all patients and in patients with AC. In patients with SCC, the diagnosis of SCC itself and the presence of STAS were risk factors for recurrence and DFS. Moreover, the risk of distant recurrence is higher in the presence of LVI or VI, and the risk of locoregional recurrence in the presence of STAS is higher.
引用
收藏
页码:121 / 130
页数:10
相关论文
共 50 条
  • [41] Adjuvant Chemotherapy in Patients With Early-Stage Non-Small Cell Lung Cancer
    Inamura, Kentaro
    JAMA ONCOLOGY, 2021, 7 (04) : 637 - 638
  • [42] Docetaxel in neoadjuvant therapy of early-stage non-small cell lung cancer
    Betticher, DC
    ONKOLOGIE, 2003, 26 : 33 - 36
  • [43] Progress in the Management of Early-Stage Non-Small Cell Lung Cancer in 2017
    Donington, Jessica S.
    Kim, Young Tae
    Tong, Betty
    Moreira, Andre L.
    Bessich, Jamie
    Weiss, Kathleen D.
    Colson, Yolonda L.
    Wigle, Dennis
    Osarogiagbon, Raymond U.
    Zweig, Jeffrey
    Wakelee, Heather
    Blasberg, Justin
    Daly, Megan
    Backhus, Leah
    Van Schil, Paul
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (06) : 767 - 778
  • [44] Resectability versus Operability in Early-Stage Non-Small Cell Lung Cancer
    Streit, Arthur
    Lampridis, Savvas
    Seitlinger, Joseph
    Renaud, Stephane
    Routledge, Tom
    Bille, Andrea
    CURRENT ONCOLOGY REPORTS, 2024, 26 (01) : 55 - 64
  • [45] Role of Segmentectomy in Treatment of Early-Stage Non-Small Cell Lung Cancer
    Hennon, Mark
    Landreneau, Rodney J.
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 (01) : 59 - 63
  • [46] Progress in the Treatment and Outcomes for Early-Stage Non-Small Cell Lung Cancer
    Jacob Y. Shin
    Ja Kyoung Yoon
    Gaurav Marwaha
    Lung, 2018, 196 : 351 - 358
  • [47] Survivin gene expression in early-stage non-small cell lung cancer
    Falleni, M
    Pellegrini, C
    Marchetti, A
    Oprandi, B
    Buttitta, F
    Barassi, F
    Santambrogio, L
    Coggi, G
    Bosari, S
    JOURNAL OF PATHOLOGY, 2003, 200 (05): : 620 - 626
  • [48] Carbonic anhydrase IX in early-stage non-small cell lung cancer
    Kim, SJ
    Rabbani, ZN
    Vollmer, RT
    Schreiber, EG
    Oosterwijk, E
    Dewhirst, MW
    Vujaskovic, Z
    Kelley, MJ
    CLINICAL CANCER RESEARCH, 2004, 10 (23) : 7925 - 7933
  • [49] Prognostic Impact of Histology on Early-Stage Non-small Cell Lung Cancer
    Maeda, Ryo
    Yoshida, Junji
    Ishii, Genichiro
    Hishida, Tomoyuki
    Nishimura, Mitsuyo
    Nagai, Kanji
    CHEST, 2011, 140 (01) : 135 - 145
  • [50] Early-stage non-small cell lung cancer: A SEER database analysis
    Ganti, A. K.
    Shostrom, V.
    Islam, K. M.
    Marr, A. S.
    Smith, L.
    Kessinger, M. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)